Challenges in developing and implementing international best practice guidance for intermediate-risk variants in cancer susceptibility genes:APC c.3920T>A p.(Ile1307Lys) as an exemplar

J Med Genet. 2024 May 2:jmg-2024-109900. DOI: 10.1136/jmg-2024-109900 Online ahead of print.

Terri Patricia McVeighFiona LallooIan M FraylingAndrew LatchfordKatie SnapeMiranda DurkieKevin J MonahanHelen Hanson

https://pubmed.ncbi.nlm.nih.gov/38697781/

International consensus is needed on a core outcome set to advance the evidence of best practice in cancer prehabilitation services and research

Br J Anaesth. 2024 Mar 23:S0007-0912(24)00100-4. DOI: 10.1016/j.bja.2024.02.021 Online ahead of print.

Anna M MyersRachael C BarlowGabriele BaldiniAnna M CampbellFranco CarliEsther J CarrTom CollyerGerard DanjouxJune F DavisLinda DenehyJames DurrandChelsia GillisDiana M GreenfieldStuart P GriffithsMike GrocottLiam HumphreysSandy JackCarol KeenDenny Z H LevettZoe MerchantJohn MooreSusan MougWilliam RickettsDaniel Santa MinaJohn M SaxtonClare E ShawGarry A TewMichael ThelwellMalcolm A WestRobert J Copeland

https://pubmed.ncbi.nlm.nih.gov/38522964

Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review

BMC Cancer. 2023 Sep 4;23(1):820. DOI: 10.1186/s12885-023-11300-8

Emma L O’Dowd # Samuel W D Merriel # Vinton W T Cheng Sam Khan Lynne M Howells Dipesh P Gopal Elizabeth A Roundhill Paul M Brennan Philip A J Crosbie  Richard D Neal Karen Brown Emma J Crosbie  David R Baldwin 

https://pubmed.ncbi.nlm.nih.gov/37667231/